TAGMol: Target-Aware Gradient-guided Molecule Generation
- URL: http://arxiv.org/abs/2406.01650v1
- Date: Mon, 3 Jun 2024 14:43:54 GMT
- Title: TAGMol: Target-Aware Gradient-guided Molecule Generation
- Authors: Vineeth Dorna, D. Subhalingam, Keshav Kolluru, Shreshth Tuli, Mrityunjay Singh, Saurabh Singal, N. M. Anoop Krishnan, Sayan Ranu,
- Abstract summary: 3D generative models have shown significant promise in structure-based drug design (SBDD)
We decouple the problem into molecular generation and property prediction.
The latter synergistically guides the diffusion sampling process, facilitating guided diffusion and resulting in the creation of meaningful molecules with the desired properties.
We call this guided molecular generation process as TAGMol.
- Score: 19.977071499171903
- License: http://creativecommons.org/licenses/by/4.0/
- Abstract: 3D generative models have shown significant promise in structure-based drug design (SBDD), particularly in discovering ligands tailored to specific target binding sites. Existing algorithms often focus primarily on ligand-target binding, characterized by binding affinity. Moreover, models trained solely on target-ligand distribution may fall short in addressing the broader objectives of drug discovery, such as the development of novel ligands with desired properties like drug-likeness, and synthesizability, underscoring the multifaceted nature of the drug design process. To overcome these challenges, we decouple the problem into molecular generation and property prediction. The latter synergistically guides the diffusion sampling process, facilitating guided diffusion and resulting in the creation of meaningful molecules with the desired properties. We call this guided molecular generation process as TAGMol. Through experiments on benchmark datasets, TAGMol demonstrates superior performance compared to state-of-the-art baselines, achieving a 22% improvement in average Vina Score and yielding favorable outcomes in essential auxiliary properties. This establishes TAGMol as a comprehensive framework for drug generation.
Related papers
- Decomposed Direct Preference Optimization for Structure-Based Drug Design [47.561983733291804]
We propose a new structure-based molecular optimization method called DecompDPO.
It decomposes the molecule into arms and scaffolds and performs preference optimization at both local substructure and global molecule levels.
Experiments on the CrossDocked 2020 benchmark show that DecompDPO significantly improves model performance in both molecule generation and optimization.
arXiv Detail & Related papers (2024-07-19T02:12:25Z) - Aligning Target-Aware Molecule Diffusion Models with Exact Energy Optimization [147.7899503829411]
We propose a novel and general alignment framework to align pretrained target diffusion models with preferred functional properties, named AliDiff.
AliDiff shifts the target-conditioned chemical distribution towards regions with higher binding affinity and structural rationality, specified by user-defined reward functions.
We show that AliDiff can generate molecules with state-of-the-art binding energies with up to -7.07 Avg. Vina Score, while maintaining strong molecular properties.
arXiv Detail & Related papers (2024-07-01T06:10:29Z) - PILOT: Equivariant diffusion for pocket conditioned de novo ligand generation with multi-objective guidance via importance sampling [8.619610909783441]
We propose an in-silico approach for the $textitde novo$ generation of 3D ligand structures using the equivariant diffusion model PILOT.
Its multi-objective-based importance sampling strategy is designed to direct the model towards molecules that exhibit desired characteristics.
We employ PILOT to generate novel metrics for unseen protein pockets from the Kinodata-3D dataset.
arXiv Detail & Related papers (2024-05-23T17:58:28Z) - DecompOpt: Controllable and Decomposed Diffusion Models for Structure-based Molecular Optimization [49.85944390503957]
DecompOpt is a structure-based molecular optimization method based on a controllable and diffusion model.
We show that DecompOpt can efficiently generate molecules with improved properties than strong de novo baselines.
arXiv Detail & Related papers (2024-03-07T02:53:40Z) - DecompDiff: Diffusion Models with Decomposed Priors for Structure-Based Drug Design [62.68420322996345]
Existing structured-based drug design methods treat all ligand atoms equally.
We propose a new diffusion model, DecompDiff, with decomposed priors over arms and scaffold.
Our approach achieves state-of-the-art performance in generating high-affinity molecules.
arXiv Detail & Related papers (2024-02-26T05:21:21Z) - Leveraging Side Information for Ligand Conformation Generation using
Diffusion-Based Approaches [12.71967232020327]
Ligand molecule conformation generation is a critical challenge in drug discovery.
Deep learning models have been developed to tackle this problem.
These models often generate conformations that lack meaningful structure and randomness due to the absence of essential side information.
arXiv Detail & Related papers (2023-08-02T09:56:47Z) - Retrieval-based Controllable Molecule Generation [63.44583084888342]
We propose a new retrieval-based framework for controllable molecule generation.
We use a small set of molecules to steer the pre-trained generative model towards synthesizing molecules that satisfy the given design criteria.
Our approach is agnostic to the choice of generative models and requires no task-specific fine-tuning.
arXiv Detail & Related papers (2022-08-23T17:01:16Z) - A biologically-inspired evaluation of molecular generative machine
learning [17.623886600638716]
A novel biologically-inspired benchmark for the evaluation of molecular generative models is proposed.
We propose a recreation metric, apply drug-target affinity prediction and molecular docking as complementary techniques for the evaluation of generative outputs.
arXiv Detail & Related papers (2022-08-20T11:01:10Z) - Improved Drug-target Interaction Prediction with Intermolecular Graph
Transformer [98.8319016075089]
We propose a novel approach to model intermolecular information with a three-way Transformer-based architecture.
Intermolecular Graph Transformer (IGT) outperforms state-of-the-art approaches by 9.1% and 20.5% over the second best for binding activity and binding pose prediction respectively.
IGT exhibits promising drug screening ability against SARS-CoV-2 by identifying 83.1% active drugs that have been validated by wet-lab experiments with near-native predicted binding poses.
arXiv Detail & Related papers (2021-10-14T13:28:02Z)
This list is automatically generated from the titles and abstracts of the papers in this site.
This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.